{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:42:44Z","timestamp":1785577364755,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2456,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jcf.2006.03.007","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T13:22:44Z","timestamp":1147180964000},"page":"205-213","source":"Crossref","is-referenced-by-count":29,"title":["Inhalation solutions \u2013 which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers"],"prefix":"10.1016","volume":"5","author":[{"given":"Wolfgang","family":"Kamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Schwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2006.03.007_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","article-title":"For the society task force on the use of nebulizers. European Respiratory Society guidelines on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2006.03.007_bib2","series-title":"International pharmaceutical abstracts","first-page":"I31","author":"American Society of Health System Pharmacists Inc.","year":"2003"},{"key":"10.1016\/j.jcf.2006.03.007_bib3","series-title":"DRUGDEX\u00ae system","first-page":"121","year":"2004"},{"key":"10.1016\/j.jcf.2006.03.007_bib4","series-title":"AHFS drug information 2003","author":"American Society of Health-System Pharmacists Inc.","year":"2003"},{"key":"10.1016\/j.jcf.2006.03.007_bib5","series-title":"Handbook on injectable drugs","author":"Trissel","year":"2003"},{"key":"10.1016\/j.jcf.2006.03.007_bib6","first-page":"1387","article-title":"Stability of albuterol and tobramycin when mixed for aerosol administration","volume":"36","author":"Gooch","year":"1991","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2006.03.007_bib7","first-page":"23","article-title":"Formulation and shelf life of two solutions for inhalation","volume":"13","author":"Nagtegaal","year":"1997","journal-title":"Ziekenhuis farmacie"},{"key":"10.1016\/j.jcf.2006.03.007_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.2042-7174.1995.tb00812.x","article-title":"Stability of ipratropium bromide and salbutamol nebuliser admixtures","volume":"3","author":"Jacobson","year":"1995","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.jcf.2006.03.007_bib9","unstructured":"Hood JC, White TS. Stability of selected antibiotics solutions with albuterol and ipratropium inhalation solutions in the treatment of pulmonary infections. ASHP-Midyear-Clinical-Meeting 33 (1998) P-43E. Personal communication."},{"key":"10.1016\/j.jcf.2006.03.007_bib10","first-page":"378","article-title":"Cystic fibrosis inhalation therapy: stability of a combined salbutamol\/colistin solution","volume":"22","author":"Roberts","year":"1992","journal-title":"Aust J Hosp Pharm"},{"key":"10.1016\/j.jcf.2006.03.007_bib11","first-page":"236","article-title":"Physical chemical compatibility of cromolyn sodium inhalation solution \u2013 bronchodilator inhalant solution admixtures","volume":"53","author":"Lesko","year":"1984","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jcf.2006.03.007_bib12","first-page":"158","article-title":"An investigation of the compatibility of ipratropium and sodium cromoglycate nebuliser solutions","volume":"17","author":"Iacono","year":"1987","journal-title":"Aust J Hosp Pharm"},{"key":"10.1016\/j.jcf.2006.03.007_bib13","first-page":"241","article-title":"Compatibility of nebuliser solutions (letter)","volume":"17","author":"Turner","year":"1987","journal-title":"Aust J Hosp Pharm"},{"key":"10.1016\/j.jcf.2006.03.007_bib14","first-page":"185","article-title":"Update on the physical\u2013chemical compatibility of cromolyn sodium inhalation solution: bronchodilator inhalant solution admixtures","volume":"66","author":"Emm","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jcf.2006.03.007_bib15","first-page":"98","article-title":"Budesonide inhalation suspension is chemically compatible with other nebulizing formulations (Abstract)","volume":"118","author":"Smaldone","year":"2000","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jcf.2006.03.007_bib16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1345\/aph.1D335","article-title":"Compatibility of budesonide inhalation suspension with four nebulizing solutions","volume":"38","author":"McKenzie","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jcf.2006.03.007_bib17","unstructured":"Gr\u00f6nberg S, Magnusson P, Bladh N. Chemical compatibility of budesonide inhalation suspension (Pulmicort\u2122) with other nebulization products (Abstract). Meeting of the American Thoracic Society 2001. Personal communication."},{"key":"10.1016\/j.jcf.2006.03.007_bib18","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ajhp\/62.8.828","article-title":"Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium","volume":"62","author":"Tzung-Yiet","year":"2005","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.jcf.2006.03.007_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5173(99)00280-X","article-title":"Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone","volume":"190","author":"Rieutord","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jcf.2006.03.007_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/106002809703100416","article-title":"Compatibility of inhalation solution admixtures","volume":"31","author":"Joseph","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jcf.2006.03.007_bib21","first-page":"35","article-title":"Compatibility of nebuliser solutions","volume":"23","author":"Roberts","year":"1993","journal-title":"Aust J Hosp Pharm"},{"key":"10.1016\/j.jcf.2006.03.007_bib22","first-page":"82","article-title":"Combination solutions for bronchospasm","volume":"24","author":"Allen","year":"1999","journal-title":"US-Pharmacist"},{"key":"10.1016\/j.jcf.2006.03.007_bib23","first-page":"347","article-title":"Can we mix nebuliser solutions?","volume":"6","author":"Harriman","year":"1996","journal-title":"Pharm Pract"},{"key":"10.1016\/j.jcf.2006.03.007_bib24","first-page":"121","article-title":"Compatibility of common respiratory therapy drug combinations","volume":"1","author":"Owsley","year":"1997","journal-title":"Int J Pharm Compd"},{"key":"10.1016\/j.jcf.2006.03.007_bib25","series-title":"The United States pharmacopeia","author":"United States Pharmacopeial Convention, Inc.","year":"2000"},{"key":"10.1016\/j.jcf.2006.03.007_bib26","unstructured":"Pharmacopoeia European basic edition. 4th Ed. Deutscher Apotheker Verlag, Stuttgart, Govi-Verlag-Pharmazeutischer Verlag, Eschborn; 2002."},{"key":"10.1016\/j.jcf.2006.03.007_bib27","unstructured":"Pharmacopoeia European 4th supplement. 4th Ed. Deutscher Apotheker Verlag, Stuttgart, Govi-Verlag-Pharmazeutischer Verlag, Eschborn; 2003"},{"key":"10.1016\/j.jcf.2006.03.007_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(83)90679-7","article-title":"Assessment of jet nebulisers for lung aerosol therapy","volume":"2","author":"Clay","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2006.03.007_bib29","first-page":"183S","article-title":"Budesonide inhalation suspension can be nebulized with solutions containing albuterol sulphate (Poster)","volume":"122","author":"McKenzie","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2006.03.007_bib30","unstructured":"Smaldone GC, McKenzie J, Cruz Rivera M. Effect of nebulizer volume on drug delivery: budesonide inhalation suspension. Meeting of the American Thoracic Society, 2000. Personal communication."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199306000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199306000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T14:56:58Z","timestamp":1555599418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199306000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1569199306000415"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2006.03.007","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}